Heart valves must be homologated from January 1st 1997
This article was originally published in Clinica
Companies marketing heart valves in France that do not bear the CE-marking must ensure their products are homologated by January 1st, 1997. This is the thrust of a ministerial order published in the Journal officiel on June 11th. It does not apply to homografts.
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.